Introduction {#s1}
============

In human placenta, cytotrophoblasts show two distinct patterns of differentiation. In floating villi, they differentiate into syncytiotrophoblast and form the syncytial layer. In contrast, at villus-anchoring sites, cytotrophoblasts form the stratified structure known as the cell column and differentiate into extravillous trophoblasts (EVTs) ([@DEN121C26]). EVTs acquire invasive activity in the distal part of the cell column ([@DEN121C13]) and begin to migrate towards maternal tissue. Those that migrate into the decidual tissue are called interstitial trophoblasts and those that migrate into the trophoblast shell and invade along the maternal vessels are known as endovascular trophoblasts.

Normal placental development depends on the ability of EVTs to attach to and then invade into the maternal decidua and the first third of the myometrium. This occurs in order to anchor the fetus to the maternal endometrium and then invade the maternal spiral arteries creating large-diameter, low resistance vessels that provide a means of steady perfusion of the floating villi with maternal blood ([@DEN121C17]; [@DEN121C24]; [@DEN121C1]). Insufficient trophoblast invasion of the spiral arteries has been associated with pre-eclampsia and fetal growth restriction ([@DEN121C21]; [@DEN121C25]). A recent study shows that late sporadic miscarriage is associated with abnormal trophoblast invasion and insufficient myometrial spiral artery transformation ([@DEN121C4]). Identification of the factors that control trophoblast function with regard to differentiation and invasion will thus enable better understanding of the etiology of these disorders.

Trophoblast invasion depends on a tightly controlled program of intercellular signaling mediated by growth factors, cytokines and hormones of both fetal and maternal origin ([@DEN121C32]; [@DEN121C6]). Cell adhesion molecules on the surface of EVTs play an important role in the process of entry of EVTs into the maternal decidua ([@DEN121C14]; [@DEN121C52]; [@DEN121C24]). For the invasion of EVTs, cell--cell and/or cell-extracellular matrix (ECM) interactions mediated by adhesion molecules, such as cadherins and/or integrins, has been considered to be important ([@DEN121C9]). These molecules provide the appropriate adhesion to enable traction and movement of the cells and/or impart signal between the ECM and the cell interior. When trophoblast cells acquire the invasive phenotype in the cell column, down-regulation of the integrin α~6~β~4~ and up-regulation of integrin α~5~β~1~ occurs ([@DEN121C13]). In addition, these cell surface integrins modulate trophoblast motility ([@DEN121C15]) by interactions with certain ECM components ([@DEN121C23]). For example, fibronectin (FN) is abundant where anchoring villi are formed *in vivo* and both trophoblast and maternal derived FN contribute to the ECM encountered by EVT as they infiltrate the decidua. Thus, FN acts as a bridging ligand mediating anchorage and/or migratory activity following the interaction with the cognate α~5~β~1~ integrin receptor of EVTs ([@DEN121C22]).

Invasion also involves degradation of ECM elements in the direction of migration and this requires the action of proteases, particularly the matrix metalloproteinases (MMP)2 and 9 ([@DEN121C45]; [@DEN121C47]), whose activity is physiologically regulated, at least in part, by tissue inhibitors of metalloproteinases (TIMP) which bind the MMPs with a 1:1 stoichiometry: thus the balance between MMPs and TIMPs locally at the invasive site is important.

Leukemia inhibitory factor (LIF) is a pleiotrophic cytokine and has known roles in implantation in mice ([@DEN121C5]; [@DEN121C44]; [@DEN121C48]; [@DEN121C49]; [@DEN121C28]) and has parallel functions in humans ([@DEN121C11]; [@DEN121C29]; [@DEN121C3]; [@DEN121C16]; [@DEN121C30]; [@DEN121C18]). LIF signal transduction occurs via the JAK/STAT signal transduction pathway ([@DEN121C20]; [@DEN121C50]). LIF is highly expressed in first trimester decidua and the localization of its receptor on trophoblast cells suggests paracrine actions during placentation ([@DEN121C29]; [@DEN121C42]; [@DEN121C34]; [@DEN121C40]; [@DEN121C43]; [@DEN121C27]; [@DEN121C12]). Strong expression of LIF mRNA has also been detected in decidual leukocytes, which are abundant at the implantation site, suggesting that LIF may mediate interactions between maternal decidual leukocytes and invading trophoblast cells ([@DEN121C43]). In this context, decreased production of LIF mRNA by decidual T cells is associated with unexplained recurrent abortions ([@DEN121C37]).

To determine whether LIF acts in a paracrine manner within the developing placenta to modulate the invasive capacity of trophoblast, we examined the effects of LIF on primary trophoblast cells derived from first trimester decidua, with a focus on their adhesive capacity, expression of adhesion molecules and production of MMPs and TIMPs.

Materials and Methods {#s2}
=====================

Tissue collection {#s2a}
-----------------

Normal first trimester placental tissue was obtained from healthy women of reproductive age who underwent elective termination of pregnancy (amenorrhea: 8--12 week, *n* = 14). The study was approved by the Southern Health Human Research and Ethics committee. Written informed consent was obtained from each patient before surgical intervention. Chorionic villi were washed four times in sterile saline and transferred to ice-cold medium 199 (M199) containing antibiotic--antimycotic (Invitrogen, Carlsbad, CA, USA) before transporting to the laboratory for further processing within 2 h.

EVT cell preparation {#s2b}
--------------------

Primary EVT cells were prepared from chorionic villi as previously described ([@DEN121C24]). Briefly, terminal villi trees were excised, washed twice and resuspended in diluted 1:3 growth factor reduced (GFR) matrigel (BD Biosciences, Franklin Lakes, NJ, USA). The villous tips were then transferred to flasks and maintained at 37°C coated with GFR matrigel for 20 min to allow the matrigel to set, followed by addition of Dulbecco\'s modified Eagle\'s medium (DMEM)/F12 and 10% fetal calf serum (FCS) (Invitrogen). Medium was changed every 3 days for 10--14 days to allow extensive outgrowth. Outgrowing cells were detached by digestion with 0.03% trypsin--EDTA (Invitrogen) in 0.9% phosphate-buffered saline (PBS) for 5 min at 37°C followed by neutralization of trypsin activity with 10% FCS/M199. The dispersed cells were separated from large tissue remnants using a 40 µm filter (BD Biosciences) and then placed in culture to allow expansion for another 2--3 weeks. Cell cultures were detached as above, incubated with anti-CD9 (Biosource International, Camarillo, CA, USA) and subjected to negative immunomagnetic separation using MiniMacs columns (Miltenyi Biotech, Bergisch-Gladbach, Germany) to eliminate CD9-positive placental fibroblast mesenchymal cells ([@DEN121C33]; [@DEN121C51]).

The trophoblast cell fraction was washed three times and cells seeded at a density of 10^6^ cells/ml in DMEM/F12 supplemented as above. To determine the purity of the immunopurified population of EVT cells, cells were seeded on GFR Matrigel-precoated eight- chamber culture slides, (Becton--Dickinson Labware). The human EVT-hybridoma cell-line AC1M88 ([@DEN121C8]; [@DEN121C19]), to be used as a positive control, was seeded on uncoated culture slides. AC1M88 and EVT cells were incubated in DMEM/F12 medium (Sigma), supplemented with 10% FCS under standard conditions for 24--48 h. Cells were then washed three times with PBS, fixed for 5 min with ice-cold ethanol, dried and stored at −20°C until immunohistochemistry for cytokeratin (CK7) and HLA-G was performed. Only cell preparations in which \>95% of the cells were positive for CK7 were used for subsequent experiments.

EVT cells were cultured in T25 flasks (Nunc) and grown to 60--70% confluency in DMEM/F12 containing 1% antibiotics (penicillin, streptomycin and fungizone, Commonwealth Serum Laboratories, Melbourne, VIC, Australia) and 10% FCS (complete medium). The cells were washed twice with PBS free of Ca^2+^ and Mg^2+^ (PBS-) and stepped down to DMEM/F12 supplemented with 0.2% FCS and 1% of antibiotics for 24 h. This medium was changed and LIF (50 ng/ml; AMRAD, Melbourne, Australia) or vehicle (DMEM/F12) added. After a further 24 h cells were harvested, and conditioned medium stored as aliquots −20°C until assayed.

Immunocytochemistry {#s2c}
-------------------

Immunocytochemistry for the trophoblast-specific CK7 and the EVT-specific marker HLA-G was performed on the cells using anti-human CK7 (1:100 dilution, clone OV-TL 12/30, DakoCytomation, Glostrup, Denmark) and anti-human HLA-G (1:200 dilution, clone 4H84, BD Pharmingen, San Diego, CA, USA), respectively. The human EVT-hybridoma cell-line ACI.88 described elsewhere ([@DEN121C19]; [@DEN121C36]) as used as a positive control for the detection of both antigens. For the negative control, non-immune mouse immunoglobulin (Ig)G (DakoCytomation) was substituted for primary antibody at the same protein concentration.

Fixed cells on culture slides were rehydrated and treated with 3% hydrogen peroxide in distilled water for 10 min to block endogenous peroxidase activity. Cells were then washed with tris buffered saline (TBS) and incubated with non-immune block for 30 min. Primary antibody was applied and incubated at 4°C for 16 h followed by biotinylated horse anti-mouse IgG (1:200) for 30 min, then streptavidin--biotin--peroxidase complex ABC (DakoCytomation) according to the manufacturer\'s instructions. Peroxidase activity was visualized by application of diaminobenzidine substrate (DakoCtyomation) for 3--5 min. Cells were counterstained with Harris haematoxylin (Sigma), air dried and mounted. Only cell preparations in which \>95% of the cells were positive for CK7 were used for subsequent experiments.

RNA preparation and quantitative real-time RT--PCR {#s2d}
--------------------------------------------------

EVT cells were treated with or without LIF (50 ng/ml) for 24 h. EVT cell cultures were lysed with RLT buffer (QIAGEN, Germantown, MD, USA) and stored at −80°C until used. Total RNA was extracted from samples with the RNeasy Minikit (QIAGEN) according to the manufacturer\'s protocol. Genomic DNA contamination was removed by RNase-free DNase set (QIAGEN). RNA yield, purity and concentration were determined by spectrophotometry and 1 µg of each RNA was run on a 1% agarose gel (Roche, Castle Hill, NSW, Australia) to ensure RNA integrity.

Two micrograms of RNA was converted to complementary DNA (cDNA) by using Superscript III RNA polymerase, random primer, RNase inhibitor (RNaseOUT), deoxynucleoside triphosphates and First-Strand buffer (Invitrogen) according to the manufacturer\'s protocol. Real-time PCR analyses were performed on the Prism 7500 real-time PCR system (Applied Biosystems, Foster City, CA, USA) in triplicate (final reaction volume, 25 µl) in 96-well Micro Optical plates (Applied Biosystems). For each sample, 25 ng of cDNA was added to a PCR mix made with the five times Fast-Start SYBR green master mix containing Rox (Roche Diagnostics, Indianapolis, IN, USA) and 400 nM of primers. The sequences for the primers are shown in Table [I](#DEN121TB1){ref-type="table"}. The PCR protocol was: 50°C for 2 min; 95°C for 10 min; and 40 cycles of 95°C for 15 s followed by 60°C for 1 min. Relative expression levels were calculated by the comparative cycle threshold method (ΔΔ*C*~t~) as outlined in the manufacturer\'s user manual, with β-actin serving as the endogenous control for normalization. The entire real-time RT--PCR run was performed twice.

###### 

Sequences for primers used in the quantitative analysis of mRNA by real-time RT--PCR.

  Gene    Description             Primer sequences 5′-3′ (forward/reverse)
  ------- ----------------------- -----------------------------------------------------
  ACTB    β-Actin                 AGCCTCGCCTTTGCCGA/GCGCGGCGATATCATCATC
  ITGA1   Integrin α~1~ subunit   GAAAACGTGACCCATGAGTTCA/GAAAACGTGACCCATGAGTTCA
  ITGA5   Integrin α~5~ subunit   GCCTGTGGAGTACAAGTCCTT/AATTCGGGTGAAGTTATCTGTGG
  ITGA6   Integrin α~6~ subunit   GCTGGTTATAATCCTTCAATATCAATTGT/TTGGGCTCAGAACCTTGGTTT
  ITGB1   Integrin β~1~ subunit   GTGGTTGCTGGAATTGTTCTTATT/TTTTCCCTCATACTTCGGATTGAC
  ITGB4   Integrin β~4~ subunit   CTGTGTGCACGAGGGACATT/AAGGCTGACTCGGTGGAGAA
  ITGAV   Integrin α~V~ subunit   GAAAAGAATGACACGGTTGC/AGTGATGAGATGGTCCCGCT
  ITB3    Integrin β~3~ subunit   ACTGCCTGTGACTCCGACT/CGCGTGGTACAGTTGCAGTAG

ECM and adhesion molecule quantitative PCR arrays {#s2e}
-------------------------------------------------

Screening for the expression of 83 genes associated with cell adhesion and ECM molecules in EVT cell cultures under control conditions (*n* = 2, triplicate arrays per EVT culture) was conducted using the Human ECM and Adhesion Molecules RT2 Profiler PCR array (SuperArray Bioscience Corp., Frederick, MD, USA) according to the manufacturer\'s instructions. In brief, cDNA was prepared from 1 µg total RNA by using a RT2 PCR array first strand kit. PCR amplification was conducted with an initial 10-min step at 95°C followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The fluorescent SYBR Green signal was detected immediately after the extension step of each cycle, and the cycle at which the product was first detectable was recorded as the cycle threshold. Data were imported into an Excel database and analysed using the comparative cycle threshold method with normalization of the raw data to β-actin.

Cell adhesion assays {#s2f}
--------------------

EVT cells were treated with or without LIF (50 ng/ml) for 24 h. Cells were then washed with PBS-, dissociated in trypsin--EDTA, rinsed twice in PBS- and resuspended in DMEM. EVT cells were plated in triplicate at 2 × 10^4^cells/well on 96-well FN, vitronectin (VN), laminin (LN) or bovine serum albumin-coated CytoMatrix cell adhesion strips (Chemicon International, Inc.) according to the manufacturer\'s instructions and incubated at 37°C for 1 h. Cells were rinsed three times with PBS containing calcium and magnesium and stained for 5 min with 0.2% crystal violet dissolved in 10% ethanol. After five washes with PBS, crystal violet was eluted with 0.1 M NaH~2~PO~4~ containing 50% ethanol for 15 min and the optical densities (OD) were measured at 570 nm.

Gelatin zymography for latent and active forms of MMP2 and MMP9 {#s2g}
---------------------------------------------------------------

Both latent and active forms of MMP2 and MMP9 were analysed in culture medium by zymography on 10% sodium dodecyl sulphate (SDS)--polyacrylamide gels containing 1 mg/ml gelatine (all reagents from Bio-Rad, North Ryde, Australia) under non-reducing conditions. Culture medium from baby hamster kidney cells that had been stably transfected with human MMP9 (Edwards, University of East Anglia, Norwich, UK) was used for MMP2 and MMP9 standards as described previously ([@DEN121C41]). MMP identity of all bands was confirmed by incubation of parallel gels in the presence of EDTA (5 mmol/l) and by activation of latent enzymes by incubation of the culture medium with 4-aminophenyl mercuric acid (APMA) for 3 h at 37°C prior to running on a gel. Gelatinase activity was visualized by negative staining and semi-quantiated by densitometric analysis of zymograms as previously described ([@DEN121C41]). All samples for comparison were run on the same gel.

TIMP-1 and -2 enzyme-linked immunosorbent assay {#s2h}
-----------------------------------------------

TIMP-1 and -2 protein secreted from primary EVT cells was assayed by enzyme-linked immunosorbent assay (ELISA) (R&D Systems Inc., Minneapolis, MN, USA). The conditioned media from primary EVT cells were used in a 1:10 dilution to ensure that TIMP levels fell within the range of the standards in the assays. The lower detection limit of the assay was 0.08 ng/ml, and inter- and intra-assay variability were \<7 and \<5%, respectively.

Western blot analysis for signal transducer and activator of transcription 3 (STAT3) protein and phosphorylated STAT3 in primary EVT cells {#s2i}
------------------------------------------------------------------------------------------------------------------------------------------

Confluent EVT cells were either untreated or treated with LIF (50 ng/ml) with or without a newly described superpotent LIF antagonist (LA) (20 nM, [@DEN121C50]) for 15 min. The medium was aspirated, and cells washed with ice-cold sterile PBS, twice on ice. Cells were lysed and scraped in ice-cold lysis buffer containing 50 mM Tris base, 150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 25 mM NaF, 25 mM β-glycerolphosphate (pH 7.5) and 2 µl/well protease inhibitors cocktail set III \[4-(2-aminoethyl)benzenesulfonyl fluoride, 100 mM HCl, 80 µM aprotinin, 5 µM bestatin, 1.5 mm E-64, 2 mM leupeptin hemisulfate and 1 mm pepstatin A (Calbiochem, San Diego, CA, USA)\]. Cell extracts were then centrifuged and supernatant protein was quantified using the BCA protein assay kit (Pierce, Rockford, IL, USA). Equal amounts of total protein were then resolved by SDS--polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. All membranes were incubated with Ponceau S (Sigma) to ensure equal protein loading in all lanes (results not shown). The membranes were blocked with 5% non-fat dry milk in TBS, washed and probed separately with antibodies specific for phosphorylated STAT3 (Tyr705; Cell Signaling Technology Inc., Beverly, MA, USA) (1:1000) or total STAT3 (Cell Signaling Technology) (1:1000). The membranes were washed and then incubated with horse-radish peroxidase (HRP)-conjugated rabbit secondary antibody (DakoCytomation, Glostrup, Denmark) (1:1500). Finally, the HRP activity was detected using enhanced chemiluminescence reagent (Pierce). The membranes were exposed to autoradiographic film (Amersham Biosciences, Little Chalfont, UK) with the exposure time adjusted to keep the integrated OD within a linear and non-saturated range.

Statistical analyses {#s2j}
--------------------

Data are expressed as mean ± SEM fold change for each treatment compared to control. For each independent experiment treatment, values were expressed as a percentage of controls and statistical analysis was then carried out on the data from different experiments. Statistical analysis was performed using the Mann--Whitney test when comparing more than two groups or Student\'s *t*-test when comparing two groups (*P* \< 0.05 was taken as significant) using PRISM version 3.00 for Windows (GraphPad).

Results {#s3}
=======

Characterization of EVT cells {#s3a}
-----------------------------

Immunocytochemical analyses of the cells cultured on GFR-matrigel coated slides showed that CK7 and HLA-G were present in \>80% of the attached cells (Fig. [1](#DEN121F1){ref-type="fig"}A and B, respectively). The choriocarcinoma-fusion cell line AC1M88 was used as a positive control for both antigens (Fig. [1](#DEN121F1){ref-type="fig"}D and E). Replacement of primary antibodies with non-immune IgG resulted in a lack of immunostaining (Fig. [1](#DEN121F1){ref-type="fig"}C and F).

![Immunocytochemical staining of cytokeratin (CK)7 and HLA-G in primary extravillous trophoblast (EVT).\
(**A**--**C**) Primary EVT cells. (A) CK7 staining. (**B**) HLA-G staining. (C) Negative control for **B**. (D-F) AC1M88 cells (human EVT-hybridoma) (**D**) CK7 staining. (**E**) HLA-G staining. (**F**) Negative control for D. Scale bar = 50 µm. Positive staining is brown.](den12101){#DEN121F1}

Effect of LIF on EVT adhesion {#s3b}
-----------------------------

To investigate whether LIF had an effect on the adhesion of trophoblast to different ECM elements, trophoblast cells were incubated on FN, LN or VN coated wells. In the unstimulated state, trophoblast cells adhered more to FN compared to VN and LN (Fig. [2](#DEN121F2){ref-type="fig"}A). When trophoblast cells were treated with 50 ng/ml of LIF for 24 h, there was a significant increase of binding to FN, VN and LN of 20, 20 and 29%, respectively (*P* \< 0.05 for FN and VN and *P* \< 0.001 for LN, Mann--Whitney test; Fig. [2](#DEN121F2){ref-type="fig"}B--D).

![Effect of leukemia inhibitory factor (LIF) on adhesion of primary EVT cells to fibronectin (FN), vitronectin (VN) and laminin (LN).\
(**A**) Adhesion profile of EVT cells to FN, VN and LN under unstimulated conditions. Data show two separate experiments assayed in triplicate. (**B**--**D**) EVT cells were cultured with/without LIF (50 ng/ml) for 24 h and the adhesion to FN (B), VN (**C**) and LN (D) screened. Data represented as mean ± SEM. Data show three independent experiments. Each sample was assayed in triplicate. \**P* \< 0.005, \*\**P* \< 0.001 compared to control.](den12102){#DEN121F2}

Expression profile of adhesion molecules and ECM elements in EVT cell cultures using PCR array {#s3c}
----------------------------------------------------------------------------------------------

Since EVT cell cultures increased their adhesion to FN, LN and VN upon treatment with LIF we reasoned that such changes could be exerted via transcriptional regulation of those integrin subunits that mediate the cell adhesion to these ECM elements. As a first step, we investigated whether the ECM and adhesion molecule transcriptional expression profile of cultured EVT cells was similar to that of EVTs *in vivo* by a PCR array. The expression of each screened gene is shown corrected for β-actin in Table [II](#DEN121TB2){ref-type="table"}. Signals were detected for 98.2% of the genes screened in EVT cells under unstimulated culture conditions. Genes were ranked from highest to lowest expression levels. The protease inhibitors were some of the most highly expressed genes in the EVT cells. The FN gene was also highly expressed. Interestingly, VN was not detectable. Integrin β~1~ showed the highest mRNA expression compared to all other integrins screened. Integrins α~1~, α~6~ mRNA showed moderate expression, while integrins α~5~ and β~4~ showed low levels of gene expression.

###### 

Extracellular matrix and adhesion molecule mRNA expression in primary human EVT cells studied using PCR array.

  Symbol     UniGene     RefSeq      Mean C *C*~t~
  ---------- ----------- ----------- ---------------
  COL1A1     Hs.172928   NM_000088   1.8
  FN1        Hs.203717   NM_002026   2.9 × 10^−1^
  THBS1      Hs.164226   NM_003246   1.4
  COL6A2     Hs.420269   NM_001849   9.0
  COL5A1     Hs.210283   NM_000093   8.2
  TIMP1      Hs.522632   NM_003254   8.1 × 10^−2^
  TGFBI      Hs.369397   NM_000358   7.3
  MMP2       Hs.513617   NM_004530   6.8
  ITGB1      Hs.429052   NM_002211   6.8
  CTGF       Hs.410037   NM_001901   6.6
  TIMP2      Hs.104839   NM_003255   5.1
  COL4A2     Hs.508716   NM_001846   5.1
  SPARC      Hs.111779   NM_003118   4.2
  COL12A1    Hs.101302   NM_004370   2.5
  CTNNB1     Hs.476018   NM_001904   2.3
  CSPG2      Hs.443681   NM_004385   1.6
  CTNNA1     Hs.445981   NM_001903   1.6
  TNC        Hs.143250   NM_002160   1.5
  THBS2      Hs.371147   NM_003247   9.1 × 10^−3^
  LAMB1      Hs.489646   NM_002291   8.6
  MMP1       Hs.83169    NM_002421   8.0
  ITGA3      Hs.265829   NM_002204   7.1
  ITGB5      Hs.13155    NM_002213   4.3
  ITGAV      Hs.436873   NM_002210   4.0
  COL8A1     Hs.134830   NM_001850   3.7
  ADAMTS1    Hs.534115   NM_006988   2.7
  KAL1       Hs.521869   NM_000216   2.5
  COL16A1    Hs.368921   NM_001856   2.4
  ECM1       Hs.81071    NM_004425   2.2
  ITGA2      Hs.482077   NM_002203   2.2
  MMP16      Hs.546267   NM_005941   1.8
  SPG7       Hs.185597   NM_003119   1.8
  ITGA1      Hs.519304   NM_181501   1.2
  ICAM1      Hs.515126   NM_000201   1.0
  VCAM1      Hs.109225   NM_001078   9.2 × 10^−4^
  LAMC1      Hs.497039   NM_002293   8.7
  SGCE       Hs.371199   NM_003919   6.6
  ITGA4      Hs.553495   NM_000885   6.0
  SPP1       Hs.313      NM_000582   5.8
  THBS3      Hs.169875   NM_007112   5.0
  ITGB3      Hs.218040   NM_000212   4.7
  MMP13      Hs.2936     NM_002427   4.0
  ITGA6      Hs.133397   NM_000210   3.9
  COL6A1     Hs.474053   NM_001848   3.3
  COL11A1    Hs.523446   NM_080629   2.7
  MMP15      Hs.80343    NM_002428   2.5
  MMP9       Hs.297413   NM_004994   2.0
  NCAM1      Hs.503878   NM_000615   1.2
  MMP11      Hs.143751   NM_005940   1.0
  CTNND1     Hs.166011   NM_001331   7.7 × 10^−5^
  ADAMTS13   Hs.131433   NM_139028   6.7
  ITGA5      Hs.505654   NM_002205   6.6
  COL14A1    Hs.409662   NM_021110   6.6
  COL15A1    Hs.409034   NM_001855   5.7
  LAMA2      Hs.200841   NM_000426   3.8
  CNTN1      Hs.567249   NM_001843   2.9
  ITGA7      Hs.524484   NM_002206   2.9
  ITGB4      Hs.370255   NM_000213   2.8
  ITGA8      Hs.171311   NM_003638   2.4
  HAS1       Hs.57697    NM_001523   1.6
  CLEC3B     Hs.476092   NM_003278   1.4
  LAMA3      Hs.436367   NM_000227   1.2
  MMP3       Hs.375129   NM_002422   1.1
  MMP8       Hs.534479   NM_002424   1.0
  MMP10      Hs.2258     NM_002425   6.2 × 10^−6^
  MMP14      Hs.2399     NM_004995   4.1
  PECAM1     Hs.514412   NM_000442   4.0
  CDH1       Hs.461086   NM_004360   3.8
  LAMB3      Hs.497636   NM_000228   3.5
  CTNND2     Hs.314543   NM_001332   2.4
  MMP7       Hs.2256     NM_002423   2.2
  ADAMTS8    Hs.271605   NM_007037   7.6 × 10^−7^
  TIMP3      Hs.297324   NM_000362   6.6
  SELE       Hs.89546    NM_000450   4.5
  MMP12      Hs.1695     NM_002426   3.8
  ITGAL      Hs.174103   NM_002209   1.9
  ITGAM      Hs.172631   NM_000632   1.2
  COL7A1     Hs.476218   NM_000094   undetectable
  ITGB2      Hs.375957   NM_000211   undetectable
  LAMA1      Hs.270364   NM_005559   undetectable
  SELL       Hs.82848    NM_000655   undetectable
  SELP       Hs.73800    NM_003005   undetectable
  VTN        Hs.2257     NM_000638   undetectable

Ranked gene expression in human extravillous trophoblast cells. Data is presented as the mean of the threshold cycle values for each transcript corrected to β-actin (mean C *C*~t~).

Quantitative analysis of mRNA for integrin subunits in EVT {#s3d}
----------------------------------------------------------

We investigates whether LIF regulated EVT integrin mRNA expression in EVTs. Real-time RT--PCR was performed on EVT cell cultures untreated and treated with LIF for those integrin subunits listed in Table [I](#DEN121TB1){ref-type="table"}. A mean ΔΔ*C*~t~ value of \>1 reflects increased and a value of \<1 points to a decreased gene expression compared to control. The calculated ratios of corrected transcript levels between treated and control cells showed a change only for integrin β~4~ whose expression level decreased approximately 50% on treatment with LIF (*P* \< 0.05, Fig. [3](#DEN121F3){ref-type="fig"}).

![Effect of leukemia inhibitory factor (LIF) on integrin mRNA expression in primary EVT cells.\
EVT cells were treated with LIF (50 ng/ml for 24 h). Real-time RT--PCR data for integrin (ITG) α~1~, α~5~, α~6~, α~V~, β~1~, β~3~, β~4~ are presented as ratios obtained by the comparative cycle threshold method (ΔΔ*C*~t~) method, corrected to β-actin. Data represented as mean ± SEM. Data show three independent experiments. Each sample was assayed in triplicate. \**P* \< 0.001 compared to control.](den12103){#DEN121F3}

Effect of LIF on MMP2 and MMP9 mRNA expression and enzyme production in EVT {#s3e}
---------------------------------------------------------------------------

The profile of MMP2 and MMP9 secreted from EVT cells treated and untreated with LIF was examined by gelatine zymography. Unstimulated EVT cells secreted both MMP2 and MMP9 in their latent forms and in some cultures a weak band corresponding to active MMP2 was found. No active MMP9 was detected. However, the active forms of both MMP2 and MMP9 could be induced by APMA treatment *in vitro* (Fig. [4](#DEN121F4){ref-type="fig"}A). There were no significant differences in MMP secretion following LIF treatment of EVT cells as shown by densitometric analyses of zymograms (Fig. [4](#DEN121F4){ref-type="fig"}B and C).

![Effect of leukemia inhibitory factor (LIF) on matrix metalloproteinase (MMP)2 and MMP9 secretion from primary EVT cells.\
Cells were treated with/without LIF (LIF, 50 ng/ml) for 24 h. Cells were treated with aminomercuric acid (APMA) for 3 h at 37°C to activate MMP2 and MMP9. Standard (Std) from conditioned culture medium of BHK9 breast carcinoma cells. (**A**) Representative gelatin zymogram of three separate experiments illustrating pro (or latent) and active (act)MMP2 and MMP9. (**B**) Densitometric analysis of proMMP2. (**C**) Densitometric analysis of proMMP9. (B and C) Data represented as mean ± SEM. Data show three independent experiments. Each sample was assayed in duplicate.](den12104){#DEN121F4}

Effect of LIF on TIMP-1 and -2 secretion from EVT {#s3f}
-------------------------------------------------

Since the activities of MMP2 and MMP9 after activation are regulated by TIMPs, we analysed the levels of TIMP-1 and TIMP-2 protein in culture medium from EVT cells, without and following LIF treatment, by ELISA. Both TIMPs were significantly increased following treatment of EVT cells with LIF (Fig. [5](#DEN121F5){ref-type="fig"}, *P* \< 0.05). Real-time RT--PCR measurement of TIMP-1 and -2 mRNAs was also carried out in the treated and untreated EVT but these were not significantly altered by LIF treatment (data not shown).

![Effect of leukemia inhibitory factor (LIF) on tissue inhibitors of matrix metalloproteinase (TIMP)-1 and -2 protein secretion from primary EVT cells into culture medium.\
Cells were treated with/without LIF (LIF, 50 ng/ml) for 24 h. (**A**) TIMP-1 secretion. (**B**) TIMP-2 secretion. Data represented as mean ± SEM. Data show three independent experiments. Each sample was assayed in duplicate. \**P* \< 0.001 compared to control.](den12105){#DEN121F5}

Effect of LIF on STAT3 phosphorylation in EVT {#s3g}
---------------------------------------------

To determine the specificity and response of LIF action in EVT cells we examined the effect of blocking LIF action with a newly described LA, on LIF induced STAT3 phosphorylation. The effect of LIF on phosphorylation of STAT3 and STAT3 in EVT was examined over a 15-min time period by Western blot (Fig. [6](#DEN121F6){ref-type="fig"}). Addition of LIF to EVT cells stimulated phosphorylation of STAT3 at 15 min while co-culture of cells with LIF and a superpotent LA diminished the effect, compared with cells treated with LIF alone for 15 min (Fig. [6](#DEN121F6){ref-type="fig"}, top). STAT3 protein abundance was not affected at any time point when LIF was added to EVT (Fig. [6](#DEN121F6){ref-type="fig"}, bottom).

![Leukemia inhibitory factor (LIF) induced phosphorylation in EVT cells.\
EVT cells were cultured with LIF (50 ng/ml) for 15 min, and LIF plus superpotent LIF antagonist (LA, 20 mM) for 15 min. Cell lysates were electrophoresed by sodium dodecyl sulphate--polyacrylamide gel electrophoresis and immunoblotted with anti-p(Tyr705)STAT3 (phosphorylated signal transducer and activator of transcription, top) or anti-STAT3 (bottom) followed by horse-radish peroxidase-conjugated rabbit antiserum and chemiluminescence visualization. The data shown is from a single experiment but is representative of two independent experiments.](den12106){#DEN121F6}

Discussion {#s4}
==========

This study examined effects of LIF on human EVT cells and demonstrated that LIF stimulated their adhesion to ECM elements, decreased integrin β~4~ mRNA expression and stimulated production of TIMP-1 and -2, suggesting a role for LIF during human placental development. The effect of LIF on the invasive potential of human EVT cells has been controversial. LIF has been reported to increase fetal FN secretion and decrease gelatinase activity by first-trimester trophoblast cells, suggesting an overall inhibitory effect on trophoblast invasion ([@DEN121C7]; [@DEN121C34]). However, another report showed that LIF increased the invasion of first trimester EVT cells *in vitro* ([@DEN121C38]).

EVT cell invasion through the maternal decidua involves the adhesion, migration and invasion of EVT. EVT cell invasion is regulated by locally derived factors as well as by interactions of EVT with certain ECM components through integrins expressed in the cell surface ([@DEN121C23]). In the first trimester of pregnancy trophoblast invasion is tightly controlled. Taking a functional approach, we investigated the effect of LIF stimulation on EVT cell adhesion to some components of the ECM. We found that LIF increased the adhesion of EVT cells, a result that is relevant in the context of cell migration. Pregnancies complicated by pre-eclampsia or intrauterine growth retardation are characterized by shallow trophoblast invasion, and may result from failure to express the correct spectrum of integrins for trophoblast invasion ([@DEN121C34]). Integrins change in expression as trophoblast differentiates from the villous to extravillous phenotype. Cytotrophoblast progression through the cell column and differentiation into the invasive phenotype is normally characterized by down-regulation of the integrin α~6~β~4~, which may be a receptor of LN ([@DEN121C13]; [@DEN121C2]). Conversely, cells in the column up-regulate their production of the major FN receptor, α~5~/β~1~ ([@DEN121C13]). The profile of integrin mRNA expressed by the EVT cells in our study suggest that they are of the invasive phenotype. Integrin β~1~ mRNA was maximally expressed, while integrin α~5~ mRNA was minimally expressed. Integrins α~6~ and β~4~ mRNA were moderately to minimally expressed relative to the other integrins screened.

The adhesion profile on untreated resting EVT cell cultures in the present study was FN \> VN \> LN, similar to the profile previously demonstrated for HTR8/SVneo trophoblast cells that closely resemble ([@DEN121C46]) the phenotype of EVT cells. To identify relative levels of ECM and adhesion molecule mRNA expression in EVT cells we used real-time RT--PCR ECM and adhesion molecule specific arrays. We found that all the major adhesion molecules were expressed by EVTs.

Importantly, when EVT cells were treated with LIF we found an increase in adhesion of the cells to all three matrices with the greatest increase in adhesion to LN. Since cytotrophoblast progression through the cell column is associated with a downregulation of the integrin α~6~β~4~ (a likely LN receptor), our demonstration of a reduction in expression of the β~4~ subunit, is consistent with a role for LIF in the differentiation of trophoblast cells to the invasive phenotype. The lack of effect of LIF on other integrin subunits in our study supports previous findings using fluorescence-activated cell sorter analysis, which showed no effect of LIF on the expression of the integrin subunits α~1~, α~5~ and β~1~ by EVT cells ([@DEN121C43]).

The increase in cell adhesion to ECM elements without changes in the expression levels of the respective integrins subunits is interesting. In this regard, it has been shown that EVT integrin expression can be regulated by a variety factors including chemokines ([@DEN121C31]). Thus, it is likely that *in vivo*, a variety of factors, including LIF, act in concert to regulate EVT integrins.

Paradoxically, the integrin β~4~ subunit, that is regulated by LIF, dimerizes with the integrin α~6~ subunit to form the possible LN receptor. At the same time, the highest increase in EVT cell adhesion upon LIF treatment was to LN. Cells control adhesion via integrins by regulating the amount of integrins expressed on the cell surface and also by modulating the affinity of integrins to their substrates. It is possible that LIF does not regulate integrin α~6~β~4~ cell surface protein production. It is also likely that factors other than LIF affect the affinity of integrin α~6~β~4~ on trophoblast cells to LN. In addition, integrin α~6~β~4~ also potentially binds other ECM components suggesting that EVT cells bind to LN via mechanisms other than via integrin α~6~β~4~.

MMP2 and MMP9 have been implicated in trophoblast invasion and migration ([@DEN121C10]; [@DEN121C35]) and in one study LIF decreased the overall gelatinolytic activity of trophoblast cells ([@DEN121C7]). We also showed that secretion of latent and active forms of MMP2 and MMP9 by first trimester human EVT cells were not affected by LIF stimulation although LIF increased both TIMP-1 and -2 secretion. Importantly, secreted MMP2 and MMP9 were predominantly in latent forms, suggesting that an important level of regulation for their activity is by extracellular activation, probably by factors of maternal origin. The stimulation of TIMP secretion by LIF would provide further modulation of MMP action within the microenvironment of the EVT. This supports the previous report that gelatinase activity is inhibited in EVT cell cultures treated with LIF ([@DEN121C7]). We also verified that LIF was active in the EVT cells since co-culture of the EVT cells with LIF and LA reduced LIF-induced STAT3 activation and suggests that LIF regulated EVT function via pSTAT3.

Our findings support a role for LIF on adhesion and differentiation of trophoblast cells to the invasive phenotype, both of which are involved in trophoblast invasion: a process that if not finely regulated can result in abnormal placentation. Indeed, an abnormally persistent expression of LIF receptor on EVT cells in placental bed biopsies has been demonstrated in patients with early onset pre-eclampsia combined with intra-uterine growth reduction ([@DEN121C39]).

In conclusion, our data showed that LIF stimulated primary first trimester EVT cell adhesion to LN, VN and FN along with reduced expression of the integrin β~4~ subunit. Furthermore, LIF altered the balance between MMPs and TIMPs by increasing the secretion of TIMP-1 and -2 without alteration of MMP2 or MMP9 secretion. Overall, these changes suggest that LIF stimulates the differentiation of EVT cells toward the invasive phenotype. The study suggests that LIF has an important role in early placentation in women.
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